These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15747248)

  • 1. The rat-based neurovirulence safety test for the assessment of mumps virus neurovirulence in humans: an international collaborative study.
    Rubin SA; Afzal MA; Powell CL; Bentley ML; Auda GR; Taffs RE; Carbone KM
    J Infect Dis; 2005 Apr; 191(7):1123-8. PubMed ID: 15747248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mumps virus neurovirulence safety test in Rhesus monkeys: a comparison of mumps virus strains.
    Rubin SA; Snoy PJ; Wright KE; Brown EG; Reeve P; Beeler JA; Carbone KM
    J Infect Dis; 1999 Aug; 180(2):521-5. PubMed ID: 10395874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurovirulence safety testing of mumps vaccines--historical perspective and current status.
    Rubin SA; Afzal MA
    Vaccine; 2011 Apr; 29(16):2850-5. PubMed ID: 21334386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative evaluation of Leningrad-3 mumps vaccine virus neurovirulence in a neonatal rat model].
    Ignat'ev GM; Otrashevskaia EV; Rubin SA
    Vopr Virusol; 2011; 56(4):30-3. PubMed ID: 21899067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurovirulence of mumps virus: intraspinal inoculation test in marmosets.
    Saika S; Kidokoro M; Aoki A; Ohkawa T
    Biologicals; 2004 Sep; 32(3):147-52. PubMed ID: 15536045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the neurovirulence test for mumps vaccines.
    Afzal MA; Marsden SA; Hull RM; Pipkin PA; Bentley ML; Minor PD
    Biologicals; 1999 Mar; 27(1):43-9. PubMed ID: 10441402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study on the neurovirulence of different vaccine strains of parotitis virus in monkeys.
    Rozina EE; Hilgenfeldt M
    Acta Virol; 1985 May; 29(3):225-30. PubMed ID: 2864823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype.
    Rubin SA; Amexis G; Pletnikov M; Li Z; Vanderzanden J; Mauldin J; Sauder C; Malik T; Chumakov K; Carbone KM
    J Virol; 2003 Nov; 77(21):11616-24. PubMed ID: 14557647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unsuitability of the neurovirulence test for assessing the safety of vaccinal strains of the mumps virus].
    Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():101-3. PubMed ID: 262708
    [No Abstract]   [Full Text] [Related]  

  • 10. Monkey neurovirulence test for live mumps vaccine.
    Maximova O; Dragunsky E; Taffs R; Snoy P; Cogan J; Marsden S; Levenbook I
    Biologicals; 1996 Sep; 24(3):223-4. PubMed ID: 8978921
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the neurovirulence of a vaccine and a wild-type mumps virus strain in the developing rat brain.
    Rubin SA; Pletnikov M; Carbone KM
    J Virol; 1998 Oct; 72(10):8037-42. PubMed ID: 9733843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in mumps virus neurovirulence phenotype associated with quasispecies heterogeneity.
    Sauder CJ; Vandenburgh KM; Iskow RC; Malik T; Carbone KM; Rubin SA
    Virology; 2006 Jun; 350(1):48-57. PubMed ID: 16494912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of lysine at aa 335 of the hemagglutinin-neuraminidase protein of mumps virus vaccine strain Urabe AM9 is not a requirement for neurovirulence.
    Sauder CJ; Zhang CX; Link MA; Duprex WP; Carbone KM; Rubin SA
    Vaccine; 2009 Sep; 27(42):5822-9. PubMed ID: 19660591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of live mumps virus vaccines.
    Furesz J
    J Med Virol; 2002 Jul; 67(3):299-300. PubMed ID: 12116018
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of genetic mutations associated with attenuation and changes in tropism of Urabe mumps virus.
    Shah D; Vidal S; Link MA; Rubin SA; Wright KE
    J Med Virol; 2009 Jan; 81(1):130-8. PubMed ID: 19031463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of population diversity on neurovirulence potential of plaque purified L-Zagreb variants.
    Ivancic-Jelecki J; Forcic D; Jagusic M; Kosutic-Gulija T; Mazuran R; Balija ML; Isakov O; Shomron N
    Vaccine; 2016 Apr; 34(20):2383-9. PubMed ID: 27013432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety testing for neurovirulence of novel live, attenuated flavivirus vaccines: infant mice provide an accurate surrogate for the test in monkeys.
    Monath TP; Myers GA; Beck RA; Knauber M; Scappaticci K; Pullano T; Archambault WT; Catalan J; Miller C; Zhang ZX; Shin S; Pugachev K; Draper K; Levenbook IS; Guirakhoo F
    Biologicals; 2005 Sep; 33(3):131-44. PubMed ID: 15975826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
    Furesz J; Contreras G
    Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of mumps virus invasiveness in monkeys.
    Rozina EE; Kaptsova TI; Sharova OK; Nikolaeva MA; Nesterova TP
    Acta Virol; 1984 Mar; 28(2):107-13. PubMed ID: 6145343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a model to assess mumps virus neurovirulence in neonatal Wistar rats.
    Ruan J; Dong W; Liu Y; Zhang Y; Niu B; Chen Q; Fu Z; Zhu F; An Q; Tian D
    Vaccine; 2022 Oct; 40(44):6397-6403. PubMed ID: 36184403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.